Watchlist Price Alert

Estrella Immunopharma Inc... (ESLA)

NASDAQ: ESLA · Real-Time Price · USD

1.06

0.07 (7.07%)

At close: Jun 05, 2025, 3:59 PM

0.98

-7.55%

Pre-market: Jun 06, 2025, 06:10 AM EDT

Estrella Immunopharma Cash Flow Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021
Net Income	-7.31M	-996.1K	-1.69M	-733.69K
Depreciation & Amortization	n/a	n/a	n/a	n/a
Stock-Based Compensation	1.19M	n/a	129.97K	62.87K
Other Working Capital	-618.09K	576.86K	113.35K	n/a
Other Non-Cash Items	n/a	-654.07K	-1.43K	n/a
Deferred Income Tax	n/a	29.47K	n/a	n/a
Change in Working Capital	-9.95M	576.86K	113.35K	n/a
Operating Cash Flow	-16.07M	-1.04M	-1.44M	-670.82K
Capital Expenditures	-4	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-45.19M	n/a
Sales Maturities Of Investments	n/a	36.17M	n/a	n/a
Other Investing Acitivies	4.96M	n/a	n/a	n/a
Investing Cash Flow	4.96M	36.17M	-45.19M	n/a
Debt Repayment	n/a	498.6K	n/a	n/a
Common Stock Repurchased	-354.44K	-36.11M	-25K	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	4.13M	50K	530.36K	670.82K
Financial Cash Flow	12.79M	-35.56M	5.53M	670.82K
Net Cash Flow	1.69M	-438.07K	4.09M	n/a
Free Cash Flow	-16.07M	-1.04M	-1.44M	-670.82K